Simple Screening Tool Assesses Cognitive Impairment Post-COVID
Patients with post-COVID syndrome have long-term cognitive impairment that can last for more than 3 months and can be identified with the Oxford Cognitive Screen-Plus assessment, which is cost-effective, mobile, and easily used. Having a cost-effective, mobile way of assessing cognitive impairment in patients with post-COVID syndrome can provide important information that can help with predicting outcomes and making decisions regarding treatment. This can be especially helpful for patients living in rural, medically underserved areas and for other patients without needing a referral to a specialized medical facility.
@shreemoyee During the initial interviews, 69.9% of patients complained of having attentional issues, 58.9% complained of having memory problems, and 55.7% of patients complained of both. In assessing fatigue and depression, with the Brief Fatigue Inventory and the Patient Health Questionnaire-9, respectively, the patients had significantly worse scores for both than the controls (P < .0001 for both).